Cargando…

Antimicrobial Peptides: An Emerging Category of Therapeutic Agents

Antimicrobial peptides (AMPs), also known as host defense peptides, are short and generally positively charged peptides found in a wide variety of life forms from microorganisms to humans. Most AMPs have the ability to kill microbial pathogens directly, whereas others act indirectly by modulating th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahlapuu, Margit, Håkansson, Joakim, Ringstad, Lovisa, Björn, Camilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5186781/
https://www.ncbi.nlm.nih.gov/pubmed/28083516
http://dx.doi.org/10.3389/fcimb.2016.00194
_version_ 1782486706371428352
author Mahlapuu, Margit
Håkansson, Joakim
Ringstad, Lovisa
Björn, Camilla
author_facet Mahlapuu, Margit
Håkansson, Joakim
Ringstad, Lovisa
Björn, Camilla
author_sort Mahlapuu, Margit
collection PubMed
description Antimicrobial peptides (AMPs), also known as host defense peptides, are short and generally positively charged peptides found in a wide variety of life forms from microorganisms to humans. Most AMPs have the ability to kill microbial pathogens directly, whereas others act indirectly by modulating the host defense systems. Against a background of rapidly increasing resistance development to conventional antibiotics all over the world, efforts to bring AMPs into clinical use are accelerating. Several AMPs are currently being evaluated in clinical trials as novel anti-infectives, but also as new pharmacological agents to modulate the immune response, promote wound healing, and prevent post-surgical adhesions. In this review, we provide an overview of the biological role, classification, and mode of action of AMPs, discuss the opportunities and challenges to develop these peptides for clinical applications, and review the innovative formulation strategies for application of AMPs.
format Online
Article
Text
id pubmed-5186781
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-51867812017-01-12 Antimicrobial Peptides: An Emerging Category of Therapeutic Agents Mahlapuu, Margit Håkansson, Joakim Ringstad, Lovisa Björn, Camilla Front Cell Infect Microbiol Microbiology Antimicrobial peptides (AMPs), also known as host defense peptides, are short and generally positively charged peptides found in a wide variety of life forms from microorganisms to humans. Most AMPs have the ability to kill microbial pathogens directly, whereas others act indirectly by modulating the host defense systems. Against a background of rapidly increasing resistance development to conventional antibiotics all over the world, efforts to bring AMPs into clinical use are accelerating. Several AMPs are currently being evaluated in clinical trials as novel anti-infectives, but also as new pharmacological agents to modulate the immune response, promote wound healing, and prevent post-surgical adhesions. In this review, we provide an overview of the biological role, classification, and mode of action of AMPs, discuss the opportunities and challenges to develop these peptides for clinical applications, and review the innovative formulation strategies for application of AMPs. Frontiers Media S.A. 2016-12-27 /pmc/articles/PMC5186781/ /pubmed/28083516 http://dx.doi.org/10.3389/fcimb.2016.00194 Text en Copyright © 2016 Mahlapuu, Håkansson, Ringstad and Björn. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Mahlapuu, Margit
Håkansson, Joakim
Ringstad, Lovisa
Björn, Camilla
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
title Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
title_full Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
title_fullStr Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
title_full_unstemmed Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
title_short Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
title_sort antimicrobial peptides: an emerging category of therapeutic agents
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5186781/
https://www.ncbi.nlm.nih.gov/pubmed/28083516
http://dx.doi.org/10.3389/fcimb.2016.00194
work_keys_str_mv AT mahlapuumargit antimicrobialpeptidesanemergingcategoryoftherapeuticagents
AT hakanssonjoakim antimicrobialpeptidesanemergingcategoryoftherapeuticagents
AT ringstadlovisa antimicrobialpeptidesanemergingcategoryoftherapeuticagents
AT bjorncamilla antimicrobialpeptidesanemergingcategoryoftherapeuticagents